Scientists from the Department of Chemistry at Imperial have developed a small, user-friendly, accurate and cost-effective sensor to test arsenic levels in drinking water within a minute. When a drop of water hits the test strip, it gives the arsenic level count digitally.
Liver cancer is the second most common cancer with a high mortality rate worldwide. According to WHO, liver cancer is the fifth most common cancer in men and seventh most common cancer in women. Treatment could be possible only if diagnosed at an early stage. Hence research studies were conducted worldwide to find the most accurate diagnostic tool to detect liver cancer.
A clinical trial solution has been unveiled by DNAnexus that facilitates the integration of genomics data sourced from next-generation sequencing (NGS) into clinical studies. A cloud-based genomic data collection platform is offered by DNAnexus.
Last week Medibio, a company focused on how biometric markers impact mental health, launched a new app that integrates with the Apple Watch. The app works with the watch to collect biometrics, such as heart rate and then lets users see these markers in conjunction with their mental and overall health.
With a view to augment business activities and help improve product outreach; a UK-based life sciences firm has raised £1.5 million.
Drugdu.com presents their digital marketing strategy for the pharmaceutical and medical device industry and launches the Ddu Trade Accelerator to assist suppliers in expanding international business opportunities.
In a bid to sweeten its deal for Fortis Healthcare, Manipal Health Enterprises has proposed merging of both enterprises that pegs the value of the beleaguered Fortis at Rs. 8,358 crores. The buyout efforts of Manipal have been backed by US private equity firm TPG.
Midmark India, maker of medical equipment, is planning to set up its 15th center in the near future; the manufacturing unit is said to be set up in Andhra Pradesh or in Telengana.
In the first quarter of 2018, Swiss pharmaceuticals and diagnostics player Roche group’s sales rose by 6% to CHF 13.6 billion. Sales in the pharma division increased by 7% CHF 10.7 billion mainly by strong growth in Ocrevus and Perjeta.
T-Stealth™ Oncolytic Virus Platform Expected to Further Strengthen Immunotherapy Platform and Capabilities
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.